Skip to content

Author

M. C. Fidan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cetuximab-Related Skin Toxicity as a Prognostic Marker in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Analysis of the EXTREME Regimen

Cetuximab-induced skin toxicity was independently associated with improved OS in R/M HNSCC patients treated with the EXTREME regimen, suggesting its potential role as a pharmacodynamic biomarker of cetuximab efficacy.

M. Fidan, S. Safarov, H. Abbasov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.